213
Views
64
CrossRef citations to date
0
Altmetric
Original Research

A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis

, , , , , , , , & show all
Pages 46-54 | Published online: 10 Jul 2009

References

  • Hudson AJ. Amyotrophic lateral sclerosis and its association with dementia, Parkinsonism and other neurological disorders: a review. Brain 1981; 104: 217–247.
  • Przedborski S, Dhawan V, Donaldson DM et al. Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc superoxide dismutase mutations. Neurology 1996; 47: 1546–1551.
  • Ince PG, Lowe J, Shaw PJ. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 1998; 24: 104–117.
  • Wightman G, Anderson VE, Martin J et al. Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett 1992; 139: 269–274.
  • Desai J, Swash M. Extrapyramidal involvement in amyotrophic lateral sclerosis: backward falls and retropulsion. J Neurol Neurosurg Psychiatry 1999; 67: 214–216.
  • Abrahams S, Leigh PN, Kew JJ, Goldstain LH, Lloyd CM, Brooks DJ. A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis. J Neurol Sci 1995; 129: 44–46.
  • Gallassi R, Montagna P, Ciardulli C, Lorusso S, Mussuto V, Stracciari A. Cognitive impairment in motor neuron disease. Acta Neurol Scand 1985; 71: 480–484.
  • Gallassi R, Montagna P, Morreale A et al. Neuropsychological, elctroencephalogram and brain computed tomography findings in motor neuron disease. Eur Neurol 1989; 29: 115–120.
  • David AS, Gillham RH. Neuropsychological study of motor neuron disease. Psychosomatics 1986; 27: 441–445.
  • Ludolph AC, Langen KJ, Regard M et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychological and positron emission study. Acta Neurol Scand 1992; 85: 81–89.
  • Kew JJ, Goldstein LH, Leigh PN et al. The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission study. Brain 1993; 116: 1399–1423.
  • Massman PJ, Sims J, Cooke N, Haverkamp LJ, Appel V, Appel SH. Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1996; 61: 450–455.
  • Chari G, Shaw PJ, Sahgal A. Nonverbal visual attention, but not recognition memory of learning processes is impaired in motor neuron disease. Neuropsychologia 1996; 34: 377–385.
  • Abe K, Fujimura H, Toyoka K, Sakoda S, Yorifuji S, Yanagihara T. Cognitive function in amyotrophic lateral sclerosis. J Neurol Sci 1997; 148: 95–100.
  • Talbot PR, Goulding PJ, Lloyd JJ, Snowden JS, Neary D, Testa HJ. Inter-relation between ‘classic’ motor neuron disease and fronto- temporal dementia: neuropsychological and single photon emission computed tomography study. J Neurol Neurosurg Psychiatry 1995; 58: 541–547.
  • Abrahams S, Leigh PN, Harvey A, Vythelingum GN, Grise D, Goldstein LH. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis. Neuropsychologia 2000; 38: 734–747.
  • Abrahams S, Goldstein LH, Kew JJ et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis: a PET study. Brain 1996; 119: 2105–2020.
  • Lloyd CM, Richardson MP, Brooks DJ, Al-Chalabi A, Leigh PN. Extrarmotor involvement in ALS: PET studies with the GABA(A) ligand [11C]flumazenil. Brain 2000; 123: 2289–2296.
  • Gallagher JP. Pathological laughter and crying in ALS: a search for their origin. Acta Neurol Scand 1989; 80: 114–117.
  • Tedman BM, Young CA, Williams IR. Assessment of depression in patients with motor neuron disease and other neurologically disabling illnesses. J Neurol Sci 1997; 152 (Suppl 1): S75–S79.
  • Abrahams S, Goldstein LH, Al-Chalabi A et al. Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1997; 62: 464–472.
  • Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994; 124 (suppl): 96–107.
  • Norris FH, Calanchini PR, Fallat RH, Panchari S, Jewett B. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 1974; 24: 721–728.
  • Lacomblez L, Bouche P, Bensimon G, Meininger V. A double- blind placebo-controlled trial of high doses of gangliosides in amyotrophic lateral sclerosis. Neurology 1989; 39: 1635–1637.
  • Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull 1988; 24: 709–711.
  • Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–198.
  • McHugo GJ, Smith GA, Lanzetta JT. The structure of self-reports of emotional responses to film segments. Motiv Emotion 1982; 6: 635–685.
  • Philippot P. Inducing and assessing differentiated emotion feeling states in the laboratory. Cognition Emotion 1993; 7: 171–193.
  • Izard CE, Dougherty FE, Bloxom BM, Kotsch NE. The Differential Emotions Scale: a method of measuring the meaning of subjective experience of discrete emotions. Department of Psychology, Vanderbilt University, Nashville, 1974.
  • Ouss L, Carton S, Jouvent R, Widlocher D. Traduction et validation de l’e´chelle d’e´motions diffe´rentielles d’Izard. L’Ence´phale 1990; 16: 453–458.
  • Nelson HE. A modified card-sorting test sensitive to frontal lobe defects. Cortex 1976; 12: 313–324.
  • Wechsler D. Echelle d’intelligence de Wechsler pour adultes. Forme re´vise´e WAIS-R. Centre de Psychologie Applique´e, Paris, 1989.
  • Lezak MD. Neuropsychological assessment. 3rd Edition. Oxford University Press, Oxford, 1995. p. 381.
  • Rey A. L’examen clinique en psychologie. PUF, Paris, 1964.
  • Benton AL. Test de re´tention visuelle. Centre de Psychologie Applique´e, Paris, 1974.
  • Raven J. Progressive matrices. Etablissements d’Application Psychotechniques, Issy-les-Moulineaux, 1960.
  • Viaregge P, Wauschkuhn B, Heberlein I, Hagenah J, Verleger R. Selective attention is impaired in amyotrophic lateral sclerosis: a study of event related EEG potentials. Cog Br Res 1999; 8: 27–35.
  • Cobble M. Language impairment in motor neuron disease. J Neurol Sci 1998; 160 (Suppl 1): S47–S52.
  • McCullagh S, Moore M, Gawel M, Feinstein A. Pathological laughing and crying in amyotrophic lateral sclerosis: an association with prefrontal cognitive dysfunction. J Neurol Sci 1999; 169: 43–48.
  • Bixler EO, Kales A, Tan TL, Kales JD. The effects of hypnotic drugs on performance. Curr Ther Res Clin Exp 1973; 15: 13–24.
  • Moore MJ, Moore PB, Shaw PJ. Mood disturbances in motor neuron disease. J Neurol Sci 1999; 160 (Suppl 1): S53–S56.
  • Bocker FM, Seibold I, Neuendorfer B. Disability in everyday tasks and subjective status of patients with advanced amyotrophic lateral sclerosis. Fortschr Neurol Psychiatr 1990; 58: 224–236.
  • Newsom-Davis IC, Abrahams S, Goldstein LH, Leigh PN. The emotional lability qestionnaire: a new measure of emotional lability in amyotrophic lateral sclerosis. J Neurol Sci 1999; 169: 22–25.
  • Wozniak DF, Olney JW, Kettinger L, Price M, Miller JP. Behavioural effects of MK-801 in the rat. Psychopharmacology 1990; 101: 47–56.
  • Brosnan-Watters G, Wozniak DF, Nardi A, Olney JW. Acute behavioural effects of MK-801 in the mouse. Pharmacol Biochem Behav 1996; 53: 701–711.
  • Oye I, Paulsen O, Maurset A. Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate recep- tors. J Pharmacol Exp Therap 1992; 260: 1209–1213.
  • Saletu, Grunberger J, Anderer P, Linzmayer L. Effects of the novel neuroprotective agent, riluzole, on human brain function and behaviour. I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxia. Meth Find Exp Clin Pharmacol 1996; 18: 55–66.
  • Stefan K, Kunesch E, Benecke R, Classen J. Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis. Ann Neurol 2001; 49: 536–539.
  • Lomen-Hoerth, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003; 60: 1094–1097.
  • Strong MJ, Grace GM, Orange JB, Leeper HA, Menon RS, Aere C. A prospective study of cognitive impairment in ALS. Neurology 1999 Nov 10; 53(8): 1665–70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.